Deafness-associated GJB2 mutations (coding Cx26) can be classified into two groups: those that produce non-syndromic deafness and mutations that produce hearing loss associated with other signs such as skin alterations, ocular, renal or thyroid disorders (syndromic deafness). Here, GJB2 is linked to deafness.